News

2010

Medicines manufacturers have clear motives for financing the patient voice

Quito Declaration

Independent drug bulletin and assessment reports from Spain – now in English

Quito Declaration

EU Global Health Council Conclusions presented at WHA

EU Ombudsman: Transparency rules apply to all documents held by EMA

Patient groups not only for sick people's interests – says Portuguese sociologist

Citizens call for inquiry into EU response to H1N1 outbreak

European Medicines Agency faces tough questions about patient groups' transparency

HAI hosts essay competition for students

EU-India negotiations on FTA pose a serious threat to access to affordable medicines in the developing world

Patient Groups need dose of transparency

EU lobby transparency book launch by ALTER-EU

LAC-EU Alliance for Access to Medicines welcomes compulsory license by Ecuadorian Government

Roundtable on ACTA by TACD

Generic prescribing policies 1 – ABPI 0

Snooping CEO unveils conflicts of interest at the European Medicines Agency

Where to find ACTA Draft Negotiating Text

EU Global Health Communication

Patient advocacy groups: another tool to boost compliance?

Finnish study: Drug companies see added value of patient group sponsorship

No NGO briefings will be allowed during World Health Assembly this year.

HAI Response: ACTA Stakeholders Meeting in European Parliament